Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Review Best Secured Card No Annual Fee options to find the best-value cards that help you build credit without annual charges.
14,291 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
If you have $1,000 to invest today, you don’t have to chase every hot trend. Two unstoppable growth stocks right—NVID...
Hims Hers continues to blend telehealth with consumer products. This guide breaks down the key metrics from the earni...
As energy demand grows—from data centers to next-gen reactors—centrus energy stock potential captures the imagination...
A fresh budget analysis casts doubt on solvency for Social Security and Medicare, even as Trump reiterates promises t...
As biotech investors digest Recursion's latest quarterly results, this Deep Dive breaks down what recursion (rxrx) 20...
Bitcoin selling pressure weakens as a surge in U.S. spot ETF inflows shows renewed demand. This article breaks down w...
Bitcoin prices have tumbled into February 2026, fueling online theories about a Wall Street firm. Experts warn there’...
Carl Icahn’s latest stake move in Icahn Enterprises drew attention from investors. This article breaks down what icah...
A three-way bid for Warner Bros. Discovery produced three market winners, reshaping how investors view streaming, stu...
Geopolitical tensions in the Middle East sparked rapid market moves and new risks for household budgets. This piece e...
Nike is back in focus as consumer demand shows resilience and the market digests the athletic giant's performance. Th...